Evaluation of Mobile Apps Targeted at Patients With Spondyloarthritis for Disease Monitoring: Systematic App Search.
2019-10-30 13:51:11
Evaluation of Mobile Apps Targeted at Patients With Spondyloarthritis for Disease Monitoring.
"A total of 1253 apps were identified in the app stores, and 5 apps met the criteria and were further analyzed. Moreover, 2 apps (MySpA and Group for Research and Assessment of Psoriasis and Psoriatic Arthritis App) contained some of the validated disease activity monitoring instruments for specific spondyloarthritis subtypes. These 2 apps were also rated good on the MARS (with total mean scores ≥4 out of 5), whereas the other apps scored poorly in comparison."
Two apps for axial spondyloarthritis - the MySPA and GRAPPA apps are supported by this review from researchers in Singapore.
The systematic review starts from the App stores (Google Play and Apple Store) rather than the traditional database sources for scientific evidence. The apps were evaluated using the MARS (Mobile App Rating Scale) but none of the apps had been tested in clinical trials so one item from the MARS scale (evidence base) was excluded.
Patient-reported outcomes through digital devices (and wearables) are going to become more commonplace.
Source: www.ncbi.nlm.nih.gov
apps spondyloarthritis app monitoring mobile mars targeted disease
Related: